Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TSPO | P30536 | 1/20 | 0.34 |
| ▸ | EDNRA | P25101 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | GFER | P55789 | 1/20 | 0.30 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17170709 | 1.00 | KDM4E (0.36) | KDM4EATML3MBTL1TSPOEDNRA | |
| SCHEMBL17170341 | 0.97 | TSPO (0.34) | KDM4EATML3MBTL1TSPOEDNRA | |
| SCHEMBL17170711 | 0.97 | TSPO (0.34) | KDM4EATML3MBTL1TSPOEDNRA | |
| SCHEMBL17170337 | 0.96 | TSPO (0.34) | KDM4EATML3MBTL1TSPOEDNRA | |
| SCHEMBL17170703 | 0.94 | KDM4E (0.35) | KDM4EATML3MBTL1TSPOEDNRA | |
| SCHEMBL17170692 | 0.94 | KDM4E (0.35) | KDM4EATML3MBTL1TSPOEDNRA | |
| SCHEMBL17170707 | 0.91 | TSPO (0.34) | KDM4EATML3MBTL1TSPO | |
| SCHEMBL17170756 | 0.91 | L3MBTL1 (0.41) | KDM4EATML3MBTL1TSPOEDNRA | |
| SCHEMBL17170374 | 0.91 | L3MBTL1 (0.41) | KDM4EATML3MBTL1TSPOEDNRA | |
| SCHEMBL17170286 | 0.91 | L3MBTL1 (0.41) | KDM4EATML3MBTL1TSPOEDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10756277-B2 | Organic compound and organic electroluminescent device comprising the same | DOOSAN SOLUS CO., LTD. (KR) | 2020-08-25 | — | — | US | disclosed |
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | DOOSAN CORPORATION (KR) | 2017-06-15 | — | — | US | disclosed |
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | DOOSAN CORPORATION (KR) | 2017-06-15 | — | — | US | disclosed |
| WO-2015156580-A2 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | 주식회사 두산 | 2015-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | OR10J3, ORC3, L1CAM | KDM4E 909/4885ATM 1000/4885L3MBTL1 609/4885 |
| US-10756277-B2 | Organic compound and organic electroluminescent device comprising the same | OR10J3, L1CAM, ICOSLG | KDM4E 953/4885ATM 1280/4885L3MBTL1 314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.